RARE logo

RARE Stock Overview

Profile

Full Name:

Ultragenyx Pharmaceutical Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

January 31, 2014

Indexes:

Not included

Description:

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company headquartered in Novato, California, specializing in the development and implementation of new drugs for the treatment of severe rare genetic diseases. It was founded in 2010. The company focuses its efforts on developing drugs for patients with diseases that have no treatment options. Today, there are many rare genetic diseases that do not have approved therapies. The company's product portfolio includes two commercially approved products, as well as several candidates at various stages of clinical trials, which can be divided into three categories: biologics, gene therapy products, and small molecules.

Key Details

Price

$45.70

Annual Revenue

$560.23 M(+29.01% YoY)

Annual EPS

-$6.29(+23.76% YoY)

Annual ROE

-214.50%

Beta

0.91

Events Calendar

Earnings

Next earnings date:

May 2, 2025

Recent quarterly earnings:

Feb 13, 2025

Recent annual earnings:

Feb 13, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Oct 22, 24 Cantor Fitzgerald
Overweight
Oct 21, 24 TD Cowen
Buy
Oct 1, 24 Cantor Fitzgerald
Overweight
Sep 26, 24 RBC Capital
Outperform
Sep 20, 24 Cantor Fitzgerald
Overweight
Sep 16, 24 Cantor Fitzgerald
Overweight
Aug 5, 24 Barclays
Overweight
Aug 2, 24 Wells Fargo
Overweight
Aug 2, 24 Wedbush
Neutral
Aug 2, 24 Goldman Sachs
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Ultragenyx Pharmaceutical?
  • Does Ultragenyx Pharmaceutical pay dividends?
  • What sector is Ultragenyx Pharmaceutical in?
  • What industry is Ultragenyx Pharmaceutical in?
  • What country is Ultragenyx Pharmaceutical based in?
  • When did Ultragenyx Pharmaceutical go public?
  • Is Ultragenyx Pharmaceutical in the S&P 500?
  • Is Ultragenyx Pharmaceutical in the NASDAQ 100?
  • Is Ultragenyx Pharmaceutical in the Dow Jones?
  • When was Ultragenyx Pharmaceutical's last earnings report?
  • When does Ultragenyx Pharmaceutical report earnings?
  • Should I buy Ultragenyx Pharmaceutical stock now?

What is the ticker symbol for Ultragenyx Pharmaceutical?

The ticker symbol for Ultragenyx Pharmaceutical is NASDAQ:RARE

Does Ultragenyx Pharmaceutical pay dividends?

No, Ultragenyx Pharmaceutical does not pay dividends

What sector is Ultragenyx Pharmaceutical in?

Ultragenyx Pharmaceutical is in the Healthcare sector

What industry is Ultragenyx Pharmaceutical in?

Ultragenyx Pharmaceutical is in the Biotechnology industry

What country is Ultragenyx Pharmaceutical based in?

Ultragenyx Pharmaceutical is headquartered in United States

When did Ultragenyx Pharmaceutical go public?

Ultragenyx Pharmaceutical's initial public offering (IPO) was on January 31, 2014

Is Ultragenyx Pharmaceutical in the S&P 500?

No, Ultragenyx Pharmaceutical is not included in the S&P 500 index

Is Ultragenyx Pharmaceutical in the NASDAQ 100?

No, Ultragenyx Pharmaceutical is not included in the NASDAQ 100 index

Is Ultragenyx Pharmaceutical in the Dow Jones?

No, Ultragenyx Pharmaceutical is not included in the Dow Jones index

When was Ultragenyx Pharmaceutical's last earnings report?

Ultragenyx Pharmaceutical's most recent earnings report was on Feb 13, 2025

When does Ultragenyx Pharmaceutical report earnings?

The next expected earnings date for Ultragenyx Pharmaceutical is May 2, 2025

Should I buy Ultragenyx Pharmaceutical stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions